Filing Flows › ClearPoint Neuro (CLPT) › Q2 2026 › vs Q1 2026
ClearPoint Neuro (CLPT) Q2 2026 vs Q1 2026 (quarter over quarter)
ClearPoint Neuro's revenue fell $1.2M (-10%) from $12.1M in Q1 2026 to $10.9M in Q2 2026.
ClearPoint Neuro, Q2 2026: revenue $10.9M (+18% year over year), operating margin -94.2%, net loss $11.3M, operating cash flow −$7.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $10.9M | $12.1M | −$1.2M | -10% |
| Income tax benefit | $38K | −$8K | $46K | — |
| Net loss | $11.3M | $9.6M | $1.8M | +19% |
| Costs & expenses | $22.3M | $21.7M | $575K | +3% |
| Operating costs | $21.1M | $20.6M | $518K | +3% |
| Interest & other, net | $1.1M | $1.1M | $65K | +6% |
| Cost of revenue | $4.2M | $4.4M | −$202K | -5% |
| Research & development | $4.6M | $4.5M | $110K | +2% |
| SG&A | $5.6M | $5.0M | $557K | +11% |
| Other operating costs | $6.8M | $6.7M | $53K | +0.8% |
| Operating cash sources | $11.3M | $9.6M | $1.8M | +19% |
| Depreciation & amortization | $150K | $86K | $64K | +74% |
| Share-based compensation | $2.3M | $2.2M | $53K | +2% |
| Working capital & other | $1.9M | −$719K | $2.6M | — |
| Cash used in operations | $7.0M | $8.0M | −$952K | -12% |
| Net loss absorbed | $11.3M | $9.6M | $1.8M | +19% |
Questions
How much did ClearPoint Neuro's revenue grow quarter over quarter in Q2 2026?
ClearPoint Neuro's revenue fell $1.2M (-10%) from $12.1M in Q1 2026 to $10.9M in Q2 2026.